These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1958795)

  • 1. Ovarian stimulation.
    Ditkoff EC; Lobo RA
    Curr Opin Obstet Gynecol; 1991 Oct; 3(5):635-40. PubMed ID: 1958795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction.
    Tan SL
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):166-72. PubMed ID: 8193257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of LHRH analogs in ovulation induction].
    Hedon B; Bringer J; Boulot P; Audibert F; Benos P; Bachelard B; Neveu S; Arnal F; Humeau C; Mares P
    Rev Fr Gynecol Obstet; 1991 Feb; 86(2):97-9. PubMed ID: 1905834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.
    Gong F; Tang Y; Zhang H; Lu G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):185-9. PubMed ID: 19349670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of ovarian stimulation in in vitro fertilization].
    Delbaere A; Devreker F; Hannes M; Koenig I; Holoye A; Englert Y
    Rev Med Brux; 1999 Oct; 20(5):A446-52. PubMed ID: 10582480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified approach to in vitro fertilization.
    Steinkampf MP; Kretzer PA; McElroy E; Conway-Myers BA
    J Reprod Med; 1992 Mar; 37(3):199-204. PubMed ID: 1564702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation of embryos and oocytes: an update.
    Gelety T; Surrey E
    Curr Opin Obstet Gynecol; 1993 Oct; 5(5):606-14. PubMed ID: 8241436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild ovarian stimulation for IVF.
    Verberg MF; Macklon NS; Nargund G; Frydman R; Devroey P; Broekmans FJ; Fauser BC
    Hum Reprod Update; 2009; 15(1):13-29. PubMed ID: 19091755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled ovarian hyperstimulation: does prolonged stimulation justify cancellation of in vitro fertilization cycles?
    Bar-Hava I; Yoeli R; Yulzari-Roll V; Ashkenazi J; Shalev J; Orvieto R
    Gynecol Endocrinol; 2005 Oct; 21(4):232-4. PubMed ID: 16316846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program].
    Pilka L; Ventruba P; Soska J; Cupr Z; Veselý J; Tesarík J; Trávník P; Dvorák M
    Cesk Gynekol; 1987 Mar; 52(2):105-9. PubMed ID: 3107845
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vitro fertilization in women over the age of 40].
    Belaïsch-Allart J; de Mouzon J; Bachelot A; Logerot-Lebrun H; Rufat P
    Contracept Fertil Sex; 1993 May; 21(5):367-70. PubMed ID: 7920918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin.
    Al-Inany H; Aboulghar MA; Mansour RT; Serour GI
    Gynecol Endocrinol; 2005 Mar; 20(3):161-9. PubMed ID: 16019356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended induction of ovulation by human menopausal gonadotropins and a gonadotropin-releasing hormone analog in high responders for in vitro fertilization and oocyte donation.
    Amit A; Yaron Y; Azem F; Peyser MR; David MP; Lessing JB
    J Reprod Med; 1995 Sep; 40(9):633-7. PubMed ID: 8576879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to improve IVF results from a clinical point of view?].
    Rossin-Amar B
    Gynecol Obstet Fertil; 2006 Sep; 34(9):774-80. PubMed ID: 16973397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.